| MicroRNA-25-dependent up-regulation of NADPH oxidase 4 (NOX4) mediates hypercholesterolemia-induced oxidative/nitrative stress and subsequent dysfunction in the heart ZV Varga, K Kupai, G Szűcs, R Gáspár, J Pálóczi, N Faragó, Á Zvara, ... Journal of molecular and cellular cardiology 62, 111-121, 2013 | 182 | 2013 |
| Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition Z Giricz, MM Lalu, C Csonka, P Bencsik, R Schulz, P Ferdinandy Journal of Pharmacology and Experimental Therapeutics 316 (1), 154-161, 2006 | 139 | 2006 |
| Hypercholesterolemia increases myocardial oxidative and nitrosative stress thereby leading to cardiac dysfunction in apoB-100 transgenic mice T Csont, E Bereczki, P Bencsik, G Fodor, A Görbe, Á Zvara, C Csonka, ... Cardiovascular research 76 (1), 100-109, 2007 | 134 | 2007 |
| MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre-and postconditioning: protectomiRs ZV Varga, Á Zvara, N Faragó, GF Kocsis, M Pipicz, R Gáspár, P Bencsik, ... American Journal of Physiology-Heart and Circulatory Physiology 307 (2 …, 2014 | 128 | 2014 |
| Measurement of NO in biological samples C Csonka, T Páli, P Bencsik, A Görbe, P Ferdinandy, T Csont British journal of pharmacology 172 (6), 1620-1632, 2015 | 126 | 2015 |
| Definition of hidden drug cardiotoxicity: paradigm change in cardiac safety testing and its clinical implications P Ferdinandy, I Baczkó, P Bencsik, Z Giricz, A Görbe, P Pacher, ZV Varga, ... European heart journal 40 (22), 1771-1777, 2019 | 100 | 2019 |
| Measurement of myocardial infarct size in preclinical studies C Csonka, K Kupai, GF Kocsis, G Novák, V Fekete, P Bencsik, T Csont, ... Journal of pharmacological and toxicological methods 61 (2), 163-170, 2010 | 93 | 2010 |
| Cholesterol diet leads to attenuation of ischemic preconditioning-induced cardiac protection: the role of connexin 43 A Görbe, ZV Varga, K Kupai, P Bencsik, GF Kocsis, T Csont, K Boengler, ... American Journal of Physiology-Heart and Circulatory Physiology 300 (5 …, 2011 | 74 | 2011 |
| Capsaicin‐sensitive sensory neurons regulate myocardial function and gene expression pattern of rat hearts: a DNA microarray study Á Zvara, P Bencsik, G Fodor, T Csont, L Hackler Jr, M Dux, S Fürst, ... The FASEB journal 20 (1), 160-162, 2006 | 68 | 2006 |
| Functional genomics of cardioprotection by ischemic conditioning and the influence of comorbid conditions: implications in target identification Z V Varga, Z Giricz, P Bencsik, R Madonna, M Gyongyosi, R Schulz, ... Current drug targets 16 (8), 904-911, 2015 | 57 | 2015 |
| Preconditioning protects the heart in a prolonged uremic condition GF Kocsis, M Sárközy, P Bencsik, M Pipicz, ZV Varga, J Pálóczi, ... American Journal of Physiology-Heart and Circulatory Physiology 303 (10 …, 2012 | 52 | 2012 |
| Cardiac capsaicin‐sensitive sensory nerves regulate myocardial relaxation via S‐nitrosylation of SERCA: role of peroxynitrite P Bencsik, K Kupai, Z Giricz, A Görbe, I Huliak, S Fürst, L Dux, T Csont, ... British journal of pharmacology 153 (3), 488-496, 2008 | 48 | 2008 |
| Serum lipids and cardiac function correlate with nitrotyrosine and MMP activity in coronary artery disease patients P Bencsik, V Sasi, K Kiss, K Kupai, M Kolossváry, P Maurovich‐Horvat, ... European journal of clinical investigation 45 (7), 692-701, 2015 | 44 | 2015 |
| Cholesterol-enriched diet inhibits cardioprotection by ATP-sensitive K+ channel activators cromakalim and diazoxide C Csonka, K Kupai, P Bencsik, A Görbe, J Pálóczi, Á Zvara, LG Puskás, ... American Journal of Physiology-Heart and Circulatory Physiology 306 (3 …, 2014 | 41 | 2014 |
| Role of iNOS and peroxynitrite–matrix metalloproteinase-2 signaling in myocardial late preconditioning in rats P Bencsik, K Kupai, Z Giricz, A Görbe, J Pipis, Z Murlasits, GF Kocsis, ... American Journal of Physiology-Heart and Circulatory Physiology 299 (2 …, 2010 | 40 | 2010 |
| Moderate inhibition of myocardial matrix metalloproteinase-2 by ilomastat is cardioprotective P Bencsik, J Pálóczi, GF Kocsis, J Pipis, I Belecz, ZV Varga, C Csonka, ... Pharmacological Research 80, 36-42, 2014 | 38 | 2014 |
| Establishing a neurological-psychiatric biobank: banking, informatics, ethics MJ Molnar, P Bencsik Cellular immunology 244 (2), 101-104, 2006 | 33 | 2006 |
| Therapeutic potential of midkine in cardiovascular disease K Kadomatsu, P Bencsik, A Görbe, C Csonka, K Sakamoto, S Kishida, ... British Journal of Pharmacology 171 (4), 936-944, 2014 | 32 | 2014 |
| The role of peroxynitrite in chemical preconditioning with 3-nitropropionic acid in rat hearts N Turan, C Csonka, T Csont, Z Giricz, G Fodor, P Bencsik, M Gyöngyösi, ... Cardiovascular research 70 (2), 384-390, 2006 | 31 | 2006 |
| Chronic kidney disease induces left ventricular overexpression of the pro-hypertrophic microRNA-212 M Sárközy, R Gáspár, Á Zvara, A Siska, B Kővári, G Szűcs, F Márványkövi, ... Scientific Reports 9 (1), 1302, 2019 | 30 | 2019 |
Péter FerdinandySemmelweis University, Budapest; Pharmahungary Group, Szeged, HungaryE-mail megerősítve itt: pharmahungary.com
